KAYNE RICHARD A purchased 5.5% of their position (278.24K shares) of EIGER BIOPHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $72.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 11/2/2023ACC: 0001140361-23-051263
10% Owner
Since Oct 2023
+278.24K
Net shares
Net buyer
$72.8K
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
278.24K acquired
Non-Derivative Transactions5
Common Stock
Indirect
Shares
+11.99K
Price / share
$0.26
Trade value
$3.15K
% of position
0.2%
10/31/2023
5.10M→5.11M
Common Stock
Indirect
Shares
+12.35K
Price / share
$0.26
Trade value
$3.23K
% of position
0.2%
10/31/2023
5.11M→5.12M
Common Stock
Indirect
Shares
+130.51K
Price / share
$0.24
Trade value
$31.50K
% of position
2.5%
10/31/2023
5.12M→5.25M
Common Stock
Indirect
Shares
+100K
Price / share
$0.28
Trade value
$27.97K
% of position
1.9%
11/1/2023
5.25M→5.35M
Common Stock
Indirect
Shares
+23.40K
Price / share
$0.30
Trade value
$6.97K
% of position
0.4%
11/2/2023
5.35M→5.38M
Total
Net shares
+278.24K
Net value
$72.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/31/2023 | P · Purchase | +11.99K | $0.26 | $3.15K | 0.2% | 5.10M | 5.11M |
| Common Stock Indirect | 10/31/2023 | P · Purchase | +12.35K | $0.26 | $3.23K | 0.2% | 5.11M | 5.12M |
| Common Stock Indirect | 10/31/2023 | P · Purchase | +130.51K | $0.24 | $31.50K | 2.5% | 5.12M | 5.25M |
| Common Stock Indirect | 11/1/2023 | P · Purchase | +100K | $0.28 | $27.97K | 1.9% | 5.25M | 5.35M |
| Common Stock Indirect | 11/2/2023 | P · Purchase | +23.40K | $0.30 | $6.97K | 0.4% | 5.35M | 5.38M |
| Total | +278.24K | $72.82K | ||||||
Derivative Transactions0
No derivative transactions reported